Organigram Global Inc.
corporate_fare Company Profile
Organigram Global Inc. (NASDAQ:OGI) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 21 items for OGI at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-03, rated 10/10. Across its 20 most recent items scored 7 or higher, the top rating is 10/10, with 14 rated 8 or above. Recent SEC coverage for OGI spans 6-K, SCHEDULE 13D/A.
Recent high-impact activity:
- Organigram to Acquire Aurora for C$7.80/Share in Cash-and-Stock Deal Valued at ~C$561M
- Organigram Quantifies $8M-$10M Annualized Savings from Sanity Integration and Unified Global Model
- Full Sanity Earnout Amendment Agreements Filed, Including Related-Party Details
- Organigram Locks In Sanity Earnout at 85%, Unveils New Global Leadership
- Organigram Posts Record Q3 Revenue of $105.8M, Sanity Group Drives 49% Growth
Financial Snapshot
Short Interest & Short Volume
11.65 days to coverFINRA reported short interest of 4,817,403 shares in OGI as of the October 15, 2026 settlement, a 7.2% increase from the prior period — about 11.7 days to cover at its recent average daily volume. On November 2, 2026, 40.2% of OGI volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Insider Transactions
OGI files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.